| PERIOD ENDING | 25-Sep-09 | 26-Jun-09 | 27-Mar-09 | 26-Dec-08 | | Total Revenue | 101,381 | 9,837 | 182,207 | 212,799 | | Cost of Revenue | 74,154 | (590) | 146,741 | 162,974 | | | Gross Profit | 27,227 | 10,427 | 35,466 | 49,825 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 106,266 | 10,205 | 32,899 | 41,926 | | Non Recurring | (80,248) | 2,933 | 77,315 | 315,911 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,209 | (2,711) | (74,748) | (308,012) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,190 | (7,021) | 8,914 | 2,488 | | Earnings Before Interest And Taxes | 4,399 | (9,732) | (65,834) | (305,524) | | Interest Expense | 757 | (3,651) | 4,985 | 6,368 | | Income Before Tax | 3,642 | (6,081) | (70,819) | (311,892) | | Income Tax Expense | 1,368 | 1,617 | (129) | (16,881) | | Minority Interest | (352) | (99) |
-
| (140) | | | | Net Income From Continuing Ops | 2,373 | (7,797) | (70,690) | (295,151) | | | Non-recurring Events | | Discontinued Operations | (13,358) | (100,295) | (3,870) | (171) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (11,436) | (108,092) | (74,560) | (295,322) | | Preferred Stock And Other Adjustments |
-
| (12) | 12 |
-
| | | Net Income Applicable To Common Shares | ($11,436) | ($108,104) | ($74,548) | ($295,322) |
|
0.51% Nasdaq 
Income Statement
